Provided by Tiger Fintech (Singapore) Pte. Ltd.

Fortress Biotech Inc Series A P

6.35
+0.20003.25%
Post-market: 6.350.00000.00%17:39 EDT
Volume:9.37K
Turnover:55.56K
Market Cap:320.44M
PE:-2.36
High:6.35
Open:6.27
Low:5.60
Close:6.15
Loading ...
Jan 27, 2024

Major Issues Report

Form 8-K - Current report
Jan 03, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jan 03, 2024

Major Issues Report

Form 8-K - Current report
Nov 21, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Nov 21, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Nov 14, 2023

Major Issues Report

Form 8-K - Current report
Nov 14, 2023

Major Issues Report

Form 8-K - Current report
Nov 14, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 27, 2023

Correspondence

Form CORRESP - Correspondence
Oct 26, 2023

Major Issues Report

Form 8-K - Current report
Oct 11, 2023

Major Issues Report

Form 8-K - Current report
Sep 30, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Sep 30, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Sep 27, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Sep 19, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Aug 14, 2023

Major Issues Report

Form 8-K - Current report
Aug 14, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 19, 2023

Correspondence

Form CORRESP - Correspondence
Jul 06, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jun 23, 2023

Major Issues Report

Form 8-K - Current report